Novo Nordisk Inc Drug Patent Portfolio

Novo Nordisk Inc owns 20 orange book drugs protected by 61 US patents with Prandimet having the least patent protection, holding only 1 patent. And Novolog Flextouch with maximum patent protection, holding 23 patents. Given below is the list of Novo Nordisk Inc's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9968659 Liraglutide in cardiovascular conditions 09 Jul, 2037
Active
US9968659 Liraglutide in cardiovascular conditions 09 Jan, 2037
Active
US9265893 Injection button 23 Mar, 2033
Active
US9265893 Injection button 23 Sep, 2032
Active
US9132239 Dial-down mechanism for wind-up pen 01 Feb, 2032
Active
US9457154 Injection device with an end of dose feedback mechanism 27 Sep, 2027
Active
US9687611 Injection device with torsion spring and rotatable display 27 Feb, 2027
Active
US7686786 Dial-down mechanism for wind-up pen 03 Aug, 2026
Active
USRE46363 Dial-down mechanism for wind-up pen 03 Aug, 2026
Active
US10220155 Syringe device with a dose limiting mechanism and an additional safety mechanism 17 Jul, 2026
Active
US8920383 Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left 17 Jul, 2026
Active
US9775953 Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left 17 Jul, 2026
Active
US8114833 Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices 13 Feb, 2026
Active
US10357616 Injection device with an end of dose feedback mechanism 20 Jan, 2026
Active
US10376652 Automatic injection device with a top release mechanism 20 Jan, 2026
Active
US9108002 Automatic injection device with a top release mechanism 20 Jan, 2026
Active
US9616180 Automatic injection device with a top release mechanism 20 Jan, 2026
Active
US9861757 Injection device with an end of dose feedback mechanism 20 Jan, 2026
Active
US8684969 Injection device with torsion spring and rotatable display 20 Oct, 2025
Active
US8114833 Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices 13 Aug, 2025
Active
US7762994 Needle mounting system and a method for mounting a needle assembly 23 Nov, 2024
Active
US7762994 Needle mounting system and a method for mounting a needle assembly 23 May, 2024 Expired
US8579869 Needle mounting system and a method for mounting a needle assembly 30 Dec, 2023 Expired
US8579869 Needle mounting system and a method for mounting a needle assembly 30 Jun, 2023 Expired
US6268343 Derivatives of GLP-1 analogs 22 Feb, 2023 Expired
US8846618 Stable formulation of modified GLP-1 27 Dec, 2022 Expired
US7018992 Hormone composition 17 Sep, 2022 Expired
US8846618 Stable formulation of modified GLP-1 27 Jun, 2022 Expired
US6899699 Automatic injection device with reset feature 02 Jan, 2022 Expired
US8672898 Automatic injection device with reset feature 02 Jan, 2022 Expired
US9486588 Automatic injection device with reset feature 02 Jan, 2022 Expired
USRE41956 Dose setting limiter 21 Jul, 2021 Expired
US6716198 Injection device 05 Jun, 2021 Expired
USRE41956 Dose setting limiter 21 Jan, 2021 Expired
US6004297 Injection syringe 28 Jul, 2019 Expired
US5750497 Acylated insulin 16 Jun, 2019 Expired
US6004297 Injection syringe 28 Jan, 2019 Expired
USRE43834 Injection syringe 28 Jan, 2019 Expired
US6235004 Injection syringe 28 Jan, 2019 Expired
US6677358 NIDDM regimen 12 Jun, 2018 Expired
US8841252 Pharmaceutical formulation 26 Dec, 2017 Expired
US5866538 Insulin preparations containing NaCl 20 Dec, 2017 Expired
US6268343 Derivatives of GLP-1 analogs 22 Aug, 2017 Expired
US6458924 Derivatives of GLP-1 analogs 22 Aug, 2017 Expired
US7235627 Derivatives of GLP-1 analogs 22 Aug, 2017 Expired
US5860946 Instrument for inserting a suppository 01 Jul, 2017 Expired
US5866538 Insulin preparations containing NaCl 20 Jun, 2017 Expired
US5849700 Pharmaceutical formulation 15 Dec, 2015 Expired
US5849704 Pharmaceutical formulation 15 Dec, 2015 Expired
US5693027 Adaptor top 02 Jun, 2015 Expired
US5618913 Insulin analogues 07 Dec, 2014 Expired
US5693027 Adaptor top 02 Dec, 2014 Expired
US5626566 Large dose pen 06 Nov, 2014 Expired
US5618913 Insulin analogues 07 Jun, 2014 Expired
US5633352 Biosynthetic human growth hormone 27 May, 2014 Expired
US5626566 Large dose pen 06 May, 2014 Expired
US6011007 Acylated insulin 02 Feb, 2014 Expired
US6869930 Acylated insulin 02 Feb, 2014 Expired
US5547930 AspB28 insulin crystals 28 Sep, 2013 Expired
US5834422 AspB28 insulin compositions 28 Sep, 2013 Expired
US5840680 ASPB28 insulin crystals 28 Sep, 2013 Expired


Given below is the list of recent legal activities going on the following drug patents of Novo Nordisk Inc.

Activity Date Patent Number
Patent litigations
Maintenance Fee Reminder Mailed 01 Jul, 2024 US9486588
Maintenance Fee Reminder Mailed 01 Jul, 2024 US9486588
Maintenance Fee Reminder Mailed 01 Jul, 2024 US9486588
Payment of Maintenance Fee, 8th Year, Large Entity 21 Mar, 2024 US9457154
Payment of Maintenance Fee, 8th Year, Large Entity 21 Mar, 2024 US9457154
Payment of Maintenance Fee, 8th Year, Large Entity 21 Mar, 2024 US9457154
Payment of Maintenance Fee, 8th Year, Large Entity 21 Feb, 2023 US9132239
Payment of Maintenance Fee, 8th Year, Large Entity 21 Feb, 2023 US9132239
Payment of Maintenance Fee, 8th Year, Large Entity 21 Feb, 2023 US9132239
Payment of Maintenance Fee, 4th Year, Large Entity 21 Jan, 2023 US10376652
Payment of Maintenance Fee, 8th Year, Large Entity 21 Jan, 2023 US9108002
Payment of Maintenance Fee, 8th Year, Large Entity 21 Jan, 2023 US9108002
Payment of Maintenance Fee, 8th Year, Large Entity 21 Jan, 2023 US9108002
Payment of Maintenance Fee, 4th Year, Large Entity 21 Jan, 2023 US10376652
Payment of Maintenance Fee, 4th Year, Large Entity 21 Jan, 2023 US10376652


Novo Nordisk Inc's Drug Patent Litigations

Novo Nordisk Inc's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Jan 23, 2014, against patent number US9265893. The petitioner , challenged the validity of this patent, with Torben Stroem Hansen et al as the respondent. Click below to track the latest information on how companies are challenging Novo Nordisk Inc's patents.

Patent Proceeding Filing Date Status Respondent Petitioner
Patent litigations
US8114833 March, 2022 Terminated-Settled
(08 Sep, 2022)
Novo Nordisk A/S Fresenius Kabi USA, LLC
US8114833 December, 2019 Terminated-Settled
(21 Jun, 2021)
Novo Nordisk A/S et al. Pfizer Inc. et al.
US8114833 July, 2020 Terminated-Settled
(21 Jun, 2021)
Novo Nordisk A/S Pfizer Inc.
US9265893 January, 2014 Decision
(08 Sep, 2015)
Torben Stroem Hansen et al


Novo Nordisk Inc Drug Patents' Oppositions Filed in EPO

Novo Nordisk Inc drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Feb 23, 2006, by Owen Mumford Limited. This opposition was filed on patent number EP02726984A. Click below to reveal the latest opposition data.


Application Filing Date Opposition Party Legal Status
Patent litigations
EP02726984A NA Genentech, Inc. Patent maintained as amended
EP17710160A May, 2022 STADA Arzneimittel AG Granted and Under Opposition
EP17710160A May, 2022 Dr. Schön, Neymeyr & Partner Patentanwälte mbB Granted and Under Opposition
EP17710160A May, 2022 Adalvo Ltd. Granted and Under Opposition
EP17710160A May, 2022 SANDOZ AG Granted and Under Opposition
EP17710160A Apr, 2022 Teva Pharmaceutical Industries Ltd. Granted and Under Opposition
EP17196501A Dec, 2019 Hoffmann Eitle Granted and Under Opposition
EP17196501A Dec, 2019 Generics (U.K.) Limited Granted and Under Opposition
EP17196501A Dec, 2019 Dr. Reddy's Laboratories Limited Granted and Under Opposition
EP17196501A Dec, 2019 Galenicum Health S.L.U. Granted and Under Opposition
EP17196501A Dec, 2019 Teva Pharmaceutical Industries Ltd Granted and Under Opposition
EP04797453A Aug, 2018 Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB Opposition rejected
EP04797453A Aug, 2018 Generics (U.K.) Limited Opposition rejected
EP04797453A Aug, 2018 Teva Pharmaceutical Industries Ltd Opposition rejected
EP04797453A Aug, 2018 Wittkopp, Alexander Opposition rejected
EP04797453A Aug, 2018 Fresenius Kabi Deutschland GmbH Opposition rejected
EP04797453A Aug, 2018 Sandoz AG Opposition rejected
EP06701034A Jan, 2018 Schwöbel, Thilo Opposition rejected
EP01270333A Aug, 2012 Helm AG Revoked
EP01270333A Aug, 2012 Laboratorios Léon Farma, S.A. Revoked
EP06754730A Dec, 2011 Ypsomed AG Patent maintained as amended
EP06754730A Nov, 2011 WMC Matthes Consulting Patent maintained as amended
EP08708028A Jul, 2011 Bock Wolfgang Patent maintained as amended
EP06762643A Jul, 2010 Sanofi-Aventis Deutschland GmbH Patent maintained as amended
EP05796880A Jul, 2010 Stöckeler, Ferdinand Granted and Under Opposition
EP05796880A Jul, 2010 Ypsomed AG Granted and Under Opposition
EP05796880A Jul, 2010 Ferring International Center S.A. Granted and Under Opposition
EP05796880A Jul, 2010 OWEN MUMFORD LIMITED Granted and Under Opposition
EP05796880A Jul, 2010 COPERNICUS sp. zo.o. Granted and Under Opposition
EP05796880A Jul, 2010 Genentech, Inc. Granted and Under Opposition
EP06121820A May, 2010 SANOFI-AVENTIS DEUTSCHLAND GMBH Opposition rejected
EP02745182A Sep, 2008 AMYLIN PHARMACEUTICALS, INC. Opposition rejected
EP02726984A Mar, 2006 TecPharma Licensing AG Patent maintained as amended
EP02726984A Feb, 2006 OWEN MUMFORD LIMITED Patent maintained as amended


Novo Nordisk Inc's Family Patents

Novo Nordisk Inc drugs have patent protection in a total of 28 countries. It's US patent count contributes only to 23.1% of its total global patent coverage. Click below to unlock the full patent family tree.

Family Patents



Novo Nordisk Inc Drug List

Given below is the complete list of Novo Nordisk Inc's drugs and the patents protecting them.


1. Levemir

Levemir is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5750497 Acylated insulin 16 Jun, 2019
(5 years ago)
Expired
US5866538 Insulin preparations containing NaCl 20 Jun, 2017
(7 years ago)
Expired
US6011007 Acylated insulin 02 Feb, 2014
(10 years ago)
Expired
US6869930 Acylated insulin 02 Feb, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Levemir's drug page


2. Levemir Flexpen

Levemir Flexpen is protected by 8 patents, out of which 7 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9265893 Injection button 23 Sep, 2032
(7 years from now)
Active
USRE41956 Dose setting limiter 21 Jan, 2021
(3 years ago)
Expired
US5750497 Acylated insulin 16 Jun, 2019
(5 years ago)
Expired
US6004297 Injection syringe 28 Jan, 2019
(5 years ago)
Expired
USRE43834 Injection syringe 28 Jan, 2019
(5 years ago)
Expired
US5866538 Insulin preparations containing NaCl 20 Jun, 2017
(7 years ago)
Expired
US6011007 Acylated insulin 02 Feb, 2014
(10 years ago)
Expired
US6869930 Acylated insulin 02 Feb, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Levemir Flexpen's drug page


3. Levemir Flextouch

Levemir Flextouch is protected by 21 patents, out of which 7 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9132239 Dial-down mechanism for wind-up pen 01 Feb, 2032
(7 years from now)
Active
US9457154 Injection device with an end of dose feedback mechanism 27 Sep, 2027
(2 years from now)
Active
US9687611 Injection device with torsion spring and rotatable display 27 Feb, 2027
(2 years from now)
Active
US7686786 Dial-down mechanism for wind-up pen 03 Aug, 2026
(1 year, 9 months from now)
Active
USRE46363 Dial-down mechanism for wind-up pen 03 Aug, 2026
(1 year, 9 months from now)
Active
US10220155 Syringe device with a dose limiting mechanism and an additional safety mechanism 17 Jul, 2026
(1 year, 9 months from now)
Active
US8920383 Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left 17 Jul, 2026
(1 year, 9 months from now)
Active
US9775953 Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left 17 Jul, 2026
(1 year, 9 months from now)
Active
US10357616 Injection device with an end of dose feedback mechanism 20 Jan, 2026
(1 year, 3 months from now)
Active
US10376652 Automatic injection device with a top release mechanism 20 Jan, 2026
(1 year, 3 months from now)
Active
US9108002 Automatic injection device with a top release mechanism 20 Jan, 2026
(1 year, 3 months from now)
Active
US9616180 Automatic injection device with a top release mechanism 20 Jan, 2026
(1 year, 3 months from now)
Active
US9861757 Injection device with an end of dose feedback mechanism 20 Jan, 2026
(1 year, 3 months from now)
Active
US8684969 Injection device with torsion spring and rotatable display 20 Oct, 2025
(1 year, 5 days from now)
Active
US7762994 Needle mounting system and a method for mounting a needle assembly 23 May, 2024
(4 months ago)
Expired
US8579869 Needle mounting system and a method for mounting a needle assembly 30 Jun, 2023
(1 year, 3 months ago)
Expired
US6899699 Automatic injection device with reset feature 02 Jan, 2022
(2 years ago)
Expired
US8672898 Automatic injection device with reset feature 02 Jan, 2022
(2 years ago)
Expired
US9486588 Automatic injection device with reset feature 02 Jan, 2022
(2 years ago)
Expired
US5750497 Acylated insulin 16 Jun, 2019
(5 years ago)
Expired
US5866538 Insulin preparations containing NaCl 20 Jun, 2017
(7 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Levemir Flextouch's drug page


4. Levemir Innolet

Levemir Innolet is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5750497 Acylated insulin 16 Jun, 2019
(5 years ago)
Expired
US5866538 Insulin preparations containing NaCl 20 Jun, 2017
(7 years ago)
Expired
US6011007 Acylated insulin 02 Feb, 2014
(10 years ago)
Expired
US6869930 Acylated insulin 02 Feb, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Levemir Innolet's drug page


5. Levemir Penfill

Levemir Penfill is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5750497 Acylated insulin 16 Jun, 2019
(5 years ago)
Expired
US5866538 Insulin preparations containing NaCl 20 Jun, 2017
(7 years ago)
Expired
US6011007 Acylated insulin 02 Feb, 2014
(10 years ago)
Expired
US6869930 Acylated insulin 02 Feb, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Levemir Penfill's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

6. Norditropin

Norditropin is protected by 3 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5849700 Pharmaceutical formulation 15 Dec, 2015
(8 years ago)
Expired
US5849704 Pharmaceutical formulation 15 Dec, 2015
(8 years ago)
Expired
US5633352 Biosynthetic human growth hormone 27 May, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Norditropin's drug page


7. Norditropin Flexpro

Norditropin Flexpro is protected by 23 patents, out of which 9 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9132239 Dial-down mechanism for wind-up pen 01 Feb, 2032
(7 years from now)
Active
US9457154 Injection device with an end of dose feedback mechanism 27 Sep, 2027
(2 years from now)
Active
US9687611 Injection device with torsion spring and rotatable display 27 Feb, 2027
(2 years from now)
Active
US7686786 Dial-down mechanism for wind-up pen 03 Aug, 2026
(1 year, 9 months from now)
Active
USRE46363 Dial-down mechanism for wind-up pen 03 Aug, 2026
(1 year, 9 months from now)
Active
US10220155 Syringe device with a dose limiting mechanism and an additional safety mechanism 17 Jul, 2026
(1 year, 9 months from now)
Active
US8920383 Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left 17 Jul, 2026
(1 year, 9 months from now)
Active
US9775953 Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left 17 Jul, 2026
(1 year, 9 months from now)
Active
US10357616 Injection device with an end of dose feedback mechanism 20 Jan, 2026
(1 year, 3 months from now)
Active
US10376652 Automatic injection device with a top release mechanism 20 Jan, 2026
(1 year, 3 months from now)
Active
US9108002 Automatic injection device with a top release mechanism 20 Jan, 2026
(1 year, 3 months from now)
Active
US9616180 Automatic injection device with a top release mechanism 20 Jan, 2026
(1 year, 3 months from now)
Active
US9861757 Injection device with an end of dose feedback mechanism 20 Jan, 2026
(1 year, 3 months from now)
Active
US8684969 Injection device with torsion spring and rotatable display 20 Oct, 2025
(1 year, 5 days from now)
Active
US7762994 Needle mounting system and a method for mounting a needle assembly 23 May, 2024
(4 months ago)
Expired
US8579869 Needle mounting system and a method for mounting a needle assembly 30 Jun, 2023
(1 year, 3 months ago)
Expired
US6899699 Automatic injection device with reset feature 02 Jan, 2022
(2 years ago)
Expired
US8672898 Automatic injection device with reset feature 02 Jan, 2022
(2 years ago)
Expired
US9486588 Automatic injection device with reset feature 02 Jan, 2022
(2 years ago)
Expired
US6716198 Injection device 05 Jun, 2021
(3 years ago)
Expired
US8841252 Pharmaceutical formulation 26 Dec, 2017
(6 years ago)
Expired
US5849700 Pharmaceutical formulation 15 Dec, 2015
(8 years ago)
Expired
US5849704 Pharmaceutical formulation 15 Dec, 2015
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Norditropin Flexpro's drug page


8. Norditropin Nordiflex

Norditropin Nordiflex is protected by 7 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
USRE41956 Dose setting limiter 21 Jan, 2021
(3 years ago)
Expired
US6004297 Injection syringe 28 Jan, 2019
(5 years ago)
Expired
US6235004 Injection syringe 28 Jan, 2019
(5 years ago)
Expired
USRE43834 Injection syringe 28 Jan, 2019
(5 years ago)
Expired
US8841252 Pharmaceutical formulation 26 Dec, 2017
(6 years ago)
Expired
US5849700 Pharmaceutical formulation 15 Dec, 2015
(8 years ago)
Expired
US5849704 Pharmaceutical formulation 15 Dec, 2015
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Norditropin Nordiflex's drug page


9. Novolog

Novolog is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5866538
(Pediatric)
Insulin preparations containing NaCl 20 Dec, 2017
(6 years ago)
Expired
US5866538 Insulin preparations containing NaCl 20 Jun, 2017
(7 years ago)
Expired
US5618913
(Pediatric)
Insulin analogues 07 Dec, 2014
(9 years ago)
Expired
US5618913 Insulin analogues 07 Jun, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Novolog's drug page


10. Novolog Flexpen

Novolog Flexpen is protected by 12 patents, out of which 11 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9265893 Injection button 23 Sep, 2032
(7 years from now)
Active
US7762994 Needle mounting system and a method for mounting a needle assembly 23 May, 2024
(4 months ago)
Expired
US8579869 Needle mounting system and a method for mounting a needle assembly 30 Jun, 2023
(1 year, 3 months ago)
Expired
USRE41956
(Pediatric)
Dose setting limiter 21 Jul, 2021
(3 years ago)
Expired
USRE41956 Dose setting limiter 21 Jan, 2021
(3 years ago)
Expired
US6004297
(Pediatric)
Injection syringe 28 Jul, 2019
(5 years ago)
Expired
US6004297 Injection syringe 28 Jan, 2019
(5 years ago)
Expired
USRE43834 Injection syringe 28 Jan, 2019
(5 years ago)
Expired
US5866538
(Pediatric)
Insulin preparations containing NaCl 20 Dec, 2017
(6 years ago)
Expired
US5866538 Insulin preparations containing NaCl 20 Jun, 2017
(7 years ago)
Expired
US5618913
(Pediatric)
Insulin analogues 07 Dec, 2014
(9 years ago)
Expired
US5618913 Insulin analogues 07 Jun, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Novolog Flexpen's drug page


11. Novolog Flextouch

Novolog Flextouch is protected by 23 patents, out of which 9 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9132239 Dial-down mechanism for wind-up pen 01 Feb, 2032
(7 years from now)
Active
US9457154 Injection device with an end of dose feedback mechanism 27 Sep, 2027
(2 years from now)
Active
US9687611 Injection device with torsion spring and rotatable display 27 Feb, 2027
(2 years from now)
Active
US7686786 Dial-down mechanism for wind-up pen 03 Aug, 2026
(1 year, 9 months from now)
Active
USRE46363 Dial-down mechanism for wind-up pen 03 Aug, 2026
(1 year, 9 months from now)
Active
US10220155 Syringe device with a dose limiting mechanism and an additional safety mechanism 17 Jul, 2026
(1 year, 9 months from now)
Active
US8920383 Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left 17 Jul, 2026
(1 year, 9 months from now)
Active
US9775953 Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left 17 Jul, 2026
(1 year, 9 months from now)
Active
US10357616 Injection device with an end of dose feedback mechanism 20 Jan, 2026
(1 year, 3 months from now)
Active
US10376652 Automatic injection device with a top release mechanism 20 Jan, 2026
(1 year, 3 months from now)
Active
US9108002 Automatic injection device with a top release mechanism 20 Jan, 2026
(1 year, 3 months from now)
Active
US9616180 Automatic injection device with a top release mechanism 20 Jan, 2026
(1 year, 3 months from now)
Active
US9861757 Injection device with an end of dose feedback mechanism 20 Jan, 2026
(1 year, 3 months from now)
Active
US8684969 Injection device with torsion spring and rotatable display 20 Oct, 2025
(1 year, 5 days from now)
Active
US7762994 Needle mounting system and a method for mounting a needle assembly 23 May, 2024
(4 months ago)
Expired
US8579869 Needle mounting system and a method for mounting a needle assembly 30 Jun, 2023
(1 year, 3 months ago)
Expired
US6899699 Automatic injection device with reset feature 02 Jan, 2022
(2 years ago)
Expired
US8672898 Automatic injection device with reset feature 02 Jan, 2022
(2 years ago)
Expired
US9486588 Automatic injection device with reset feature 02 Jan, 2022
(2 years ago)
Expired
US5866538
(Pediatric)
Insulin preparations containing NaCl 20 Dec, 2017
(6 years ago)
Expired
US5866538 Insulin preparations containing NaCl 20 Jun, 2017
(7 years ago)
Expired
US5618913
(Pediatric)
Insulin analogues 07 Dec, 2014
(9 years ago)
Expired
US5618913 Insulin analogues 07 Jun, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Novolog Flextouch's drug page


12. Novolog Innolet

Novolog Innolet is protected by 6 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
USRE41956
(Pediatric)
Dose setting limiter 21 Jul, 2021
(3 years ago)
Expired
USRE41956 Dose setting limiter 21 Jan, 2021
(3 years ago)
Expired
US5866538
(Pediatric)
Insulin preparations containing NaCl 20 Dec, 2017
(6 years ago)
Expired
US5866538 Insulin preparations containing NaCl 20 Jun, 2017
(7 years ago)
Expired
US5618913
(Pediatric)
Insulin analogues 07 Dec, 2014
(9 years ago)
Expired
US5618913 Insulin analogues 07 Jun, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Novolog Innolet's drug page


13. Novolog Mix 50/50

Novolog Mix 50/50 is protected by 7 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5866538
(Pediatric)
Insulin preparations containing NaCl 20 Dec, 2017
(6 years ago)
Expired
US5866538 Insulin preparations containing NaCl 20 Jun, 2017
(7 years ago)
Expired
US5618913
(Pediatric)
Insulin analogues 07 Dec, 2014
(9 years ago)
Expired
US5618913 Insulin analogues 07 Jun, 2014
(10 years ago)
Expired
US5547930 AspB28 insulin crystals 28 Sep, 2013
(11 years ago)
Expired
US5834422 AspB28 insulin compositions 28 Sep, 2013
(11 years ago)
Expired
US5840680 ASPB28 insulin crystals 28 Sep, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Novolog Mix 50/50's drug page


14. Novolog Mix 70/30

Novolog Mix 70/30 is protected by 7 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5866538
(Pediatric)
Insulin preparations containing NaCl 19 Dec, 2017
(6 years ago)
Expired
US5866538 Insulin preparations containing NaCl 19 Jun, 2017
(7 years ago)
Expired
US5618913
(Pediatric)
Insulin analogues 07 Dec, 2014
(9 years ago)
Expired
US5618913 Insulin analogues 07 Jun, 2014
(10 years ago)
Expired
US5547930 AspB28 insulin crystals 28 Sep, 2013
(11 years ago)
Expired
US5834422 AspB28 insulin compositions 28 Sep, 2013
(11 years ago)
Expired
US5840680 ASPB28 insulin crystals 28 Sep, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Novolog Mix 70/30's drug page


15. Novolog Mix 70/30 Flexpen

Novolog Mix 70/30 Flexpen is protected by 13 patents, out of which 12 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9265893 Injection button 23 Sep, 2032
(7 years from now)
Active
US7762994 Needle mounting system and a method for mounting a needle assembly 23 May, 2024
(4 months ago)
Expired
US8579869 Needle mounting system and a method for mounting a needle assembly 30 Jun, 2023
(1 year, 3 months ago)
Expired
USRE41956 Dose setting limiter 21 Jan, 2021
(3 years ago)
Expired
US6004297 Injection syringe 28 Jan, 2019
(5 years ago)
Expired
USRE43834 Injection syringe 28 Jan, 2019
(5 years ago)
Expired
US5866538
(Pediatric)
Insulin preparations containing NaCl 19 Dec, 2017
(6 years ago)
Expired
US5866538 Insulin preparations containing NaCl 19 Jun, 2017
(7 years ago)
Expired
US5618913
(Pediatric)
Insulin analogues 07 Dec, 2014
(9 years ago)
Expired
US5618913 Insulin analogues 07 Jun, 2014
(10 years ago)
Expired
US5547930 AspB28 insulin crystals 28 Sep, 2013
(11 years ago)
Expired
US5834422 AspB28 insulin compositions 28 Sep, 2013
(11 years ago)
Expired
US5840680 ASPB28 insulin crystals 28 Sep, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Novolog Mix 70/30 Flexpen's drug page


16. Novolog Mix 70/30 Penfill

Novolog Mix 70/30 Penfill is protected by 7 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5866538
(Pediatric)
Insulin preparations containing NaCl 19 Dec, 2017
(6 years ago)
Expired
US5866538 Insulin preparations containing NaCl 19 Jun, 2017
(7 years ago)
Expired
US5618913
(Pediatric)
Insulin analogues 07 Dec, 2014
(9 years ago)
Expired
US5618913 Insulin analogues 07 Jun, 2014
(10 years ago)
Expired
US5547930 AspB28 insulin crystals 28 Sep, 2013
(11 years ago)
Expired
US5834422 AspB28 insulin compositions 28 Sep, 2013
(11 years ago)
Expired
US5840680 ASPB28 insulin crystals 28 Sep, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Novolog Mix 70/30 Penfill's drug page


17. Novolog Penfill

Novolog Penfill is protected by 10 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7762994 Needle mounting system and a method for mounting a needle assembly 23 May, 2024
(4 months ago)
Expired
US8579869 Needle mounting system and a method for mounting a needle assembly 30 Jun, 2023
(1 year, 3 months ago)
Expired
US5866538
(Pediatric)
Insulin preparations containing NaCl 20 Dec, 2017
(6 years ago)
Expired
US5866538 Insulin preparations containing NaCl 20 Jun, 2017
(7 years ago)
Expired
US5693027
(Pediatric)
Adaptor top 02 Jun, 2015
(9 years ago)
Expired
US5618913
(Pediatric)
Insulin analogues 07 Dec, 2014
(9 years ago)
Expired
US5693027 Adaptor top 02 Dec, 2014
(9 years ago)
Expired
US5626566
(Pediatric)
Large dose pen 06 Nov, 2014
(9 years ago)
Expired
US5618913 Insulin analogues 07 Jun, 2014
(10 years ago)
Expired
US5626566 Large dose pen 06 May, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Novolog Penfill's drug page


18. Prandimet

Prandimet is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6677358 NIDDM regimen 12 Jun, 2018
(6 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Prandimet's drug page


19. Vagifem

Vagifem is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7018992 Hormone composition 17 Sep, 2022
(2 years ago)
Expired
US5860946 Instrument for inserting a suppository 01 Jul, 2017
(7 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vagifem's drug page


20. Victoza

Victoza is protected by 20 patents, out of which 13 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9968659
(Pediatric)
Liraglutide in cardiovascular conditions 09 Jul, 2037
(12 years from now)
Active
US9968659 Liraglutide in cardiovascular conditions 09 Jan, 2037
(12 years from now)
Active
US9265893
(Pediatric)
Injection button 23 Mar, 2033
(8 years from now)
Active
US9265893 Injection button 23 Sep, 2032
(7 years from now)
Active
US8114833
(Pediatric)
Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices 13 Feb, 2026
(1 year, 3 months from now)
Active
US8114833 Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices 13 Aug, 2025
(9 months from now)
Active
US7762994
(Pediatric)
Needle mounting system and a method for mounting a needle assembly 23 Nov, 2024
(a month from now)
Active
US7762994 Needle mounting system and a method for mounting a needle assembly 23 May, 2024
(4 months ago)
Expired
US8579869
(Pediatric)
Needle mounting system and a method for mounting a needle assembly 30 Dec, 2023
(9 months ago)
Expired
US8579869 Needle mounting system and a method for mounting a needle assembly 30 Jun, 2023
(1 year, 3 months ago)
Expired
US6268343
(Pediatric)
Derivatives of GLP-1 analogs 22 Feb, 2023
(1 year, 7 months ago)
Expired
US8846618
(Pediatric)
Stable formulation of modified GLP-1 27 Dec, 2022
(1 year, 9 months ago)
Expired
US8846618 Stable formulation of modified GLP-1 27 Jun, 2022
(2 years ago)
Expired
USRE41956
(Pediatric)
Dose setting limiter 21 Jul, 2021
(3 years ago)
Expired
USRE41956 Dose setting limiter 21 Jan, 2021
(3 years ago)
Expired
US6004297 Injection syringe 28 Jan, 2019
(5 years ago)
Expired
USRE43834 Injection syringe 28 Jan, 2019
(5 years ago)
Expired
US6268343 Derivatives of GLP-1 analogs 22 Aug, 2017
(7 years ago)
Expired
US6458924 Derivatives of GLP-1 analogs 22 Aug, 2017
(7 years ago)
Expired
US7235627 Derivatives of GLP-1 analogs 22 Aug, 2017
(7 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Victoza's drug page


Novo Nordisk Inc News

Contamination problems discovered by FDA at Thermo Fisher facility in North Carolina - Fierce Pharma

11 Oct, 2024

European healthcare industry experiences significant drop in stock prices due to worries related to Novo Nordisk and AstraZeneca.

11 Oct, 2024

Information on Ozempic and Wegovy, prescription medications for weight loss: A comprehensive guide - Quartz

09 Oct, 2024

The Compounding Group takes legal action against FDA for delisting Lilly's weight loss medication from shortage catalog

07 Oct, 2024

See More